Insulinbased
Insulinbased is an umbrella term used in medical contexts to describe therapies, devices, and research approaches that rely on insulin or insulin signaling to regulate metabolism. It commonly applies to insulin‑containing drugs and delivery systems that substitute for or augment endogenous insulin, as well as to strategies that modulate insulin pathways to improve glucose control.
Most insulinbased therapies involve exogenous insulin preparations, including human insulin and longer-acting or rapid-acting analogs. They
Insulinbased therapies are central to managing type 1 diabetes and are used in many adults with type
All insulinbased products are regulated as medicines by authorities such as the U.S. FDA and the European
Historically, insulin was discovered in 1921, transforming diabetes care. Advances include rapid-acting and long-acting analogs, new